 |
|
 |
|
 |
|
Program |
Partnership |
Call to |
Saturday May 15th |
|
09:00 am |
•
•
• |
ACADEMIC SESSION V Metabolic and genetic biomarkers Chair: Carmena Rafael (Spain) The hidden faces of HLD and the non-LDL Davignon Jean (Canada) Biomarkers to predict type II diabetes - From single candidates to complex algorithmns Koenig Wolfgang (Germany) Recent genetic insights in the genetics of type II diabetes and the metabolic syndrome Froguel Philippe (France) |
10:30 am |
|
Coffee Break |
11:00 am |
•
•
• |
ACADEMIC SESSION VI No traditional risk factors of cardiometabolic disease Chair: Sadikot Shaukat M. (India) Sleep, sleep apnea and metabolic syndrome Ahmed Qanta (USA) Perivascular inflammation as a risk factor of cardiometabolic disease Guzik Tomasz (Poland) Thioredoxin (Trx) and Thioredoxin-Interacting Protein (Txnip) are new actors in human disease: example of vascular diseases and type II diabetes Rouis Mustapha (France) |
12:30 pm |
|
Lunch |
02:00 pm |
•
•
•
• |
ORAL COMMUNICATIONS SELECTED FROM ABSTRACTS Chair: Rouis Mustapha (France)
Conference 1 Associations between obesity, vitamin D deficiency and vitamin D receptor (VDR) polymorphisms in Caribbean type 2 diabetic subjects. Velayoudom Fritz-Line (France) Conference 2 Effect of apolipoprotein A5 haplotypes on plasma triglyceride is modified by total energy intake. The HAPIEE study. Hubacek Jaroslav. A. (Czek Republic) Conference 3 Fructose repress PPARα independently of PP2A in FaO hepatoma cells Alegret Maria (Spain) Conference 4 Altered surface marker expression and function of circulating neutrophils in a fructose-induced rat model of metabolic syndrome Tagzirt Madjid (France) |
03:00 pm |
|
Coffee Break |
03:30 am |
|
POSTER SESSION Chair: Fruchart Jean-Charles (France)
END OF THE CONGRESS |
